Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Mobile phone based confidential social network referrals for HIV testing (CONSORT): protocol for a randomized controlled trial
Jan Ostermann;
Bernard Njau;
Marco van Zwetselaar;
Thespina Yamanis;
Leah McClimans;
Rose Mwangi;
Meky Beti;
Amy Hobbie;
Salomé-Joelle Gass;
Tara Mtuy;
Nathan Thielman
ABSTRACT
Background:
The ubiquity of mobile phones across many high HIV prevalence settings has created opportunities to leverage mobile health (mHealth) technologies to engage social networks for HIV prevention and treatment.
Objective:
This study seeks to evaluate the acceptability and efficacy of a novel mHealth intervention, Confidential Social Network Referrals for HIV Testing (CONSORT), to nudge at-risk individuals to test for HIV.
Methods:
The study will be conducted in Moshi, Tanzania. After qualitative formative work and pilot testing, 400 clients presenting for HIV counseling and testing, and 200 persons living with HIV (PWH) and receiving care at HIV care and treatment centers will be enrolled as inviters into a randomized controlled trial. Inviters will be asked to complete a survey of their HIV risk behaviors and their social networks and then randomized into one of two study arms. Arm 1 participants will be offered to extend automated CONSORT invitations in the form of confidential Short Messaging System (SMS) messages or physical invitation cards to any of their network contacts. Arm 2 participants will be offered physical invitation cards only. The primary outcome will be uptake of HIV testing among network contacts within 30 days. Secondary outcomes will include the acceptability of CONSORT among inviters and the number of new HIV diagnoses among network contacts presenting for HIV testing.
Results:
Enrollment into the randomized controlled trial is expected to start in September 2024. Findings will be disseminated to stakeholders and published in peer-reviewed journals.
Conclusions:
If CONSORT is acceptable and effective, mobile-phone supported chain-referral methods could greatly improve the reach of HIV testing efforts. Clinical Trial: The protocol was registered in ClinicalTrials.gov (NCT05967208) on July 25, 2023.
Citation
Please cite as:
Ostermann J, Njau B, van Zwetselaar M, Yamanis T, McClimans L, Mwangi R, Beti M, Hobbie A, Gass SJ, Mtuy T, Thielman N
Mobile Phone–Based Confidential Social Network Referrals for HIV Testing (CONSORT): Protocol for a Randomized Controlled Trial